Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review

Injection-site pain (ISP) is a subjective side effect that is commonly reported with the subcutaneous administration of biological agents, yet it may only be a concern to some. Multiple factors related to the product formulation, such as pH, volume and excipients, and/or to the injection process hav...

Descripción completa

Detalles Bibliográficos
Autores principales: St Clair-Jones, Anja, Prignano, Francesca, Goncalves, Joao, Paul, Muriel, Sewerin, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672413/
https://www.ncbi.nlm.nih.gov/pubmed/33206343
http://dx.doi.org/10.1007/s40744-020-00245-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672413/
https://www.ncbi.nlm.nih.gov/pubmed/33206343
http://dx.doi.org/10.1007/s40744-020-00245-0

Ejemplares similares